Page last updated: 2024-08-18

4-butyrolactone and Cholera Infantum

4-butyrolactone has been researched along with Cholera Infantum in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chamoun-Emanuelli, AM; Cohen, ND; Dockery, HJ; Richardson, LM; Whitfield-Cargile, CM1
Aragão, KS; Carvalho, NS; Leite, JRSA; Lucetti, LT; Medeiros, JVR; Nicolau, LAD; Pacífico, DM; Souza, MHLP; Véras, LMC1

Other Studies

2 other study(ies) available for 4-butyrolactone and Cholera Infantum

ArticleYear
Effect of selective versus nonselective cyclooxygenase inhibitors on gastric ulceration scores and intestinal inflammation in horses.
    Veterinary surgery : VS, 2018, Volume: 47, Issue:6

    Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Feces; Gastrointestinal Diseases; Horse Diseases; Horses; Inflammation; Peroxidase; Phenylbutazone; Random Allocation; Stomach Ulcer; Sulfones

2018
Epiisopiloturine hydrochloride, an imidazole alkaloid isolated from Pilocarpus microphyllus leaves, protects against naproxen-induced gastrointestinal damage in rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 87

    Topics: 4-Butyrolactone; Alkaloids; Animals; Dose-Response Relationship, Drug; Gastric Mucosa; Gastrointestinal Diseases; Imidazoles; Intestinal Mucosa; Male; Naproxen; Pilocarpus; Plant Extracts; Plant Leaves; Protective Agents; Rats; Rats, Wistar

2017